Related references
Note: Only part of the references are listed.Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice
Heather A. Boger et al.
JOURNAL OF NEUROSCIENCE (2007)
Carotid body autotransplantation in Parkinson disease:: a clinical and positron emission tomography study
Adolfo Minguez-Castellanos et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Absence of ret signaling in mice causes progressive and late degeneration of the nigrostriatal system
Edgar R. Kramer et al.
PLOS BIOLOGY (2007)
A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra
H. A. Boger et al.
EXPERIMENTAL NEUROLOGY (2006)
RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice
Sanjay Jain et al.
JOURNAL OF NEUROSCIENCE (2006)
Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice
R Mejías et al.
JOURNAL OF NEUROSCIENCE (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Gloria E. Meredith et al.
MOVEMENT DISORDERS (2006)
Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation
J Villadiego et al.
JOURNAL OF NEUROSCIENCE (2005)
Localized striatal delivery of GDNF as a treatment for Parkinson disease
D Kirik et al.
NATURE NEUROSCIENCE (2004)
The subcommissural organ expresses D2, D3, D4, and D5 dopamine receptors
M Tomé et al.
CELL AND TISSUE RESEARCH (2004)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
SM Fleming et al.
JOURNAL OF NEUROSCIENCE (2004)
Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease
V Arjona et al.
NEUROSURGERY (2003)
The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family Ligands
G Paratcha et al.
CELL (2003)
Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats
J Srinivasan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases
C Zarow et al.
ARCHIVES OF NEUROLOGY (2003)
Integrin alpha v and NCAM mediate the effects of GDNF on DA neuron survival, outgrowth, DA turnover and motor activity in rats
CC Chao et al.
NEUROBIOLOGY OF AGING (2003)
Evidence of the subcommissural organ in humans and its association with hydrocephalus
M Galarza
NEUROSURGICAL REVIEW (2002)
Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse
S Hayashi et al.
DEVELOPMENTAL BIOLOGY (2002)
A Cre recombinase transgene with mosaic, widespread tamoxifen-inducible action
CY Guo et al.
GENESIS (2002)
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
M Sedelis et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)
Share Paper
